Merck & Co (NYSE: MRK)

• Support level
  $96.66
• Resistance level
  N/A

• Beta
  0.1
• RSI (14-day)
  75.9

• MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
• The price of this low-beta stock is expected to increase by 0.1 percent for every 1% increase in the S&P-500.

• Volatility is forecast to fall over the next month.
• With RSI > 70, MRK is overbought. Odds slightly favor a short-term price reversal.
• Price broke above prior resistance level - a short-term bullish signal.

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

• In the next week
  5.8%
• In the next month
  12.9%
• In the next year
  57.8%